{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T11:30:22Z","timestamp":1794483022432,"version":"4.9.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Microbiol"],"DOI":"10.1038\/s41564-025-02168-4","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T10:04:40Z","timestamp":1762250680000},"page":"3191-3201","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Structural and mechanistic insights into herpesvirus helicase\u2013primase and its therapeutic inhibitors"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3575-9909","authenticated-orcid":false,"given":"Qing","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1651-334X","authenticated-orcid":false,"given":"Alexandre","family":"Mercier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arabinda","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey","family":"May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pui Yan","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Lewis-Ballester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8121-9052","authenticated-orcid":false,"given":"Varsha","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annapurna","family":"Sapre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Aeschbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jit","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0832-8951","authenticated-orcid":false,"given":"Christopher","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Mateo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aesop","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9461-1475","authenticated-orcid":false,"given":"Eric","family":"Lansdon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinchao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,4]]},"reference":[{"key":"2168_CR1","doi-asserted-by":"crossref","unstructured":"Arvin, A. et al. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (Cambridge Univ. Press, 2007).","DOI":"10.1017\/CBO9780511545313"},{"key":"2168_CR2","doi-asserted-by":"publisher","first-page":"e13526","DOI":"10.1111\/ctr.13526","volume":"33","author":"DH Lee","year":"2019","unstructured":"Lee, D. H. & Zuckerman, R. A. Herpes simplex virus infections in solid organ transplantation: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin. Transplant. 33, e13526 (2019).","journal-title":"Clin. Transplant."},{"key":"2168_CR3","doi-asserted-by":"publisher","first-page":"e13622","DOI":"10.1111\/ctr.13622","volume":"33","author":"SA Pergam","year":"2019","unstructured":"Pergam, S. A. & Limaye, A. P. Varicella zoster virus in solid organ transplantation: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin. Transpl. 33, e13622 (2019).","journal-title":"Clin. Transpl."},{"key":"2168_CR4","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0140-6736(96)10149-5","volume":"349","author":"RF Itzhaki","year":"1997","unstructured":"Itzhaki, R. F. et al. Herpes simplex virus type 1 in brain and risk of Alzheimer\u2019s disease. Lancet 349, 241\u2013244 (1997).","journal-title":"Lancet"},{"key":"2168_CR5","doi-asserted-by":"publisher","unstructured":"Taquet, M., Dercon, Q., Todd, J. A. & Harrison, P. J. The recombinant shingles vaccine is associated with lower risk of dementia. Nat. Med. https:\/\/doi.org\/10.1038\/s41591-024-03201-5 (2024).","DOI":"10.1038\/s41591-024-03201-5"},{"key":"2168_CR6","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3233\/JAD-191337","volume":"75","author":"YN Ou","year":"2020","unstructured":"Ou, Y. N. et al. Associations of infectious agents with Alzheimer\u2019s disease: a systematic review and meta-analysis. J. Alzheimers Dis. 75, 299\u2013309 (2020).","journal-title":"J. Alzheimers Dis."},{"key":"2168_CR7","doi-asserted-by":"publisher","unstructured":"Chen, V. C. et al. Herpes zoster and dementia: a nationwide population-based cohort study. J. Clin. Psychiatry https:\/\/doi.org\/10.4088\/JCP.16m11312 (2018).","DOI":"10.4088\/JCP.16m11312"},{"key":"2168_CR8","doi-asserted-by":"publisher","unstructured":"Mertz, G. J. Long-term acyclovir suppression of frequently recurring genital herpes simplex virus infection. J. Am. Med. Assoc. https:\/\/doi.org\/10.1001\/jama.1988.03410020067030 (1988).","DOI":"10.1001\/jama.1988.03410020067030"},{"key":"2168_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa035144","volume":"350","author":"L Corey","year":"2004","unstructured":"Corey, L. et al. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N. Engl. J. Med. 350, 11\u201320 (2004).","journal-title":"N. Engl. J. Med."},{"key":"2168_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2022.115322","volume":"206","author":"HH Schalkwijk","year":"2022","unstructured":"Schalkwijk, H. H., Snoeck, R. & Andrei, G. Acyclovir resistance in herpes simplex viruses: prevalence and therapeutic alternatives. Biochem. Pharmacol. 206, 115322 (2022).","journal-title":"Biochem. Pharmacol."},{"key":"2168_CR11","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1042\/BST20170096","volume":"45","author":"AK Byrd","year":"2017","unstructured":"Byrd, A. K. & Raney, K. D. Structure and function of Pif1 helicase. Biochem. Soc. Trans. 45, 1159\u20131171 (2017).","journal-title":"Biochem. Soc. Trans."},{"key":"2168_CR12","doi-asserted-by":"publisher","first-page":"24451","DOI":"10.1074\/jbc.270.41.24451","volume":"270","author":"AF Taylor","year":"1995","unstructured":"Taylor, A. F. & Smith, G. R. Monomeric RecBCD enzyme binds and unwinds DNA. J. Biol. Chem. 270, 24451\u201324458 (1995).","journal-title":"J. Biol. Chem."},{"key":"2168_CR13","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1146\/annurev.biochem.76.052305.115300","volume":"76","author":"MR Singleton","year":"2007","unstructured":"Singleton, M. R., Dillingham, M. S. & Wigley, D. B. Structure and mechanism of helicases and nucleic acid translocases. Annu. Rev. Biochem. 76, 23\u201350 (2007).","journal-title":"Annu. Rev. Biochem."},{"key":"2168_CR14","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.210011","volume":"11","author":"O Bermek","year":"2021","unstructured":"Bermek, O. & Williams, R. S. The three-component helicase\/primase complex of herpes simplex virus-1. Open Biol. 11, 210011 (2021).","journal-title":"Open Biol."},{"key":"2168_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2025.106152","volume":"237","author":"A Birkmann","year":"2025","unstructured":"Birkmann, A. & Saunders, R. Overview on the management of herpes simplex virus infections: current therapies and future directions. Antivir. Res. 237, 106152 (2025).","journal-title":"Antivir. Res."},{"key":"2168_CR16","unstructured":"ClinicalTrial.gov https:\/\/clinicaltrials.gov\/study\/NCT03073967 (2017)."},{"key":"2168_CR17","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1111\/1346-8138.15393","volume":"47","author":"N Shoji","year":"2020","unstructured":"Shoji, N. et al. Pharmaceuticals and Medical Device Agency approval summary: amenamevir for the treatment of herpes zoster. J. Dermatol. 47, 683\u2013688 (2020).","journal-title":"J. Dermatol."},{"key":"2168_CR18","unstructured":"Maruho receives manufacturing and marketing approval for a partial change of the indication and dosage\/administration for anti-herpes rirus agent \u201cAmenalief Tab. 200mg\u201d for the treatment of recurrent Herpes Simplex in Japan. Maruho News https:\/\/www.maruho.co.jp\/english\/information\/20230224.html (2023)."},{"key":"2168_CR19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.4155\/fmc.13.192","volume":"6","author":"S Biswas","year":"2014","unstructured":"Biswas, S., Sukla, S. & Field, H. J. Helicase\u2013primase inhibitors for herpes simplex virus: looking to the future of non-nucleoside inhibitors for treating herpes virus infections. Future Med. Chem. 6, 45\u201355 (2014).","journal-title":"Future Med. Chem."},{"key":"2168_CR20","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1093\/jac\/dkm182","volume":"60","author":"S Biswas","year":"2007","unstructured":"Biswas, S., Smith, C. & Field, H. J. Detection of HSV-1 variants highly resistant to the helicase\u2013primase inhibitor BAY 57-1293 at high frequency in 2 of 10 recent clinical isolates of HSV-1. J. Antimicrob. Chemother. 60, 274\u2013279 (2007).","journal-title":"J. Antimicrob. Chemother."},{"key":"2168_CR21","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00494-21","volume":"65","author":"Y Sato","year":"2021","unstructured":"Sato, Y. et al. Characteristics of helicase\u2013primase inhibitor amenamevir-resistant herpes simplex virus. Antimicrob. Agents Chemother. 65, e0049421 (2021).","journal-title":"Antimicrob. Agents Chemother."},{"key":"2168_CR22","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1007\/s00705-007-0964-7","volume":"152","author":"S Biswas","year":"2007","unstructured":"Biswas, S., Jennens, L. & Field, H. J. Single amino acid substitutions in the HSV-1 helicase protein that confer resistance to the helicase\u2013primase inhibitor BAY 57-1293 are associated with increased or decreased virus growth characteristics in tissue culture. Arch. Virol. 152, 1489\u20131500 (2007).","journal-title":"Arch. Virol."},{"key":"2168_CR23","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1093\/jac\/dkn057","volume":"61","author":"S Biswas","year":"2008","unstructured":"Biswas, S. et al. A single drug-resistance mutation in HSV-1 UL52 primase points to a difference between two helicase\u2013primase inhibitors in their mode of interaction with the antiviral target. J. Antimicrob. Chemother. 61, 1044\u20131047 (2008).","journal-title":"J. Antimicrob. Chemother."},{"key":"2168_CR24","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1099\/vir.0.011221-0","volume":"90","author":"S Biswas","year":"2009","unstructured":"Biswas, S., Miguel, R. N., Sukla, S. & Field, H. J. A mutation in helicase motif IV of herpes simplex virus type 1 UL5 that results in reduced growth in vitro and lower virulence in a murine infection model is related to the predicted helicase structure. J. Gen. Virol. 90, 1937\u20131942 (2009).","journal-title":"J. Gen. Virol."},{"key":"2168_CR25","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1093\/jac\/dkq198","volume":"65","author":"K Chono","year":"2010","unstructured":"Chono, K. et al. ASP2151, a novel helicase\u2013primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2. J. Antimicrob. Chemother. 65, 1733\u20131741 (2010).","journal-title":"J. Antimicrob. Chemother."},{"key":"2168_CR26","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nm0402-392","volume":"8","author":"G Kleymann","year":"2002","unstructured":"Kleymann, G. et al. New helicase\u2013primase inhibitors as drug candidates for the treatment of herpes simplex disease. Nat. Med. 8, 392\u2013398 (2002).","journal-title":"Nat. Med."},{"key":"2168_CR27","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.cell.2009.03.036","volume":"137","author":"K Saikrishnan","year":"2009","unstructured":"Saikrishnan, K., Powell, B., Cook, N. J., Webb, M. R. & Wigley, D. B. Mechanistic basis of 5\u2032-3\u2032 translocation in SF1B helicases. Cell 137, 849\u2013859 (2009).","journal-title":"Cell"},{"key":"2168_CR28","doi-asserted-by":"publisher","first-page":"15134","DOI":"10.1074\/jbc.M111.328153","volume":"287","author":"Y Komoriya","year":"2012","unstructured":"Komoriya, Y. et al. Principal role of the arginine finger in rotary catalysis of F1-ATPase. J. Biol. Chem. 287, 15134\u201315142 (2012).","journal-title":"J. Biol. Chem."},{"key":"2168_CR29","doi-asserted-by":"publisher","first-page":"E8041","DOI":"10.1073\/pnas.1612394113","volume":"113","author":"D Mann","year":"2016","unstructured":"Mann, D. et al. Mechanism of the intrinsic arginine finger in heterotrimeric G proteins. Proc. Natl Acad. Sci. USA 113, E8041\u2013E8050 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2168_CR30","doi-asserted-by":"publisher","first-page":"6029","DOI":"10.1093\/nar\/gkm544","volume":"35","author":"H Ren","year":"2007","unstructured":"Ren, H. et al. The arginine finger of the Bloom syndrome protein: its structural organization and its role in energy coupling. Nucleic Acids Res. 35, 6029\u20136041 (2007).","journal-title":"Nucleic Acids Res."},{"key":"2168_CR31","unstructured":"Strelow J. D. W. et al. in Assay Guidance Manual (ed. Grossman, A. et al.) 1\u201327 (NCATS, 2012)."},{"key":"2168_CR32","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1517\/14728222.2013.827663","volume":"17","author":"SK Weller","year":"2013","unstructured":"Weller, S. K. & Kuchta, R. D. The DNA helicase\u2013primase complex as a target for herpes viral infection. Expert Opin. Ther. Targets 17, 1119\u20131132 (2013).","journal-title":"Expert Opin. Ther. Targets"},{"key":"2168_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2022.105521","volume":"211","author":"JR Spengler","year":"2023","unstructured":"Spengler, J. R. et al. Meeting report: 35th International Conference on Antiviral Research in Seattle, Washington, USA - March 21\u201325, 2022. Antivir. Res. 211, 105521 (2023).","journal-title":"Antivir. Res."},{"key":"2168_CR34","unstructured":"ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT06435507 (2024)."},{"key":"2168_CR35","doi-asserted-by":"publisher","unstructured":"Hou, J. et al. Pharmacokinetics and safety study of HN0037, a novel anti-human herpes simplex virus inhibitor, in healthy volunteers. Clin. Pharmacol. Drug Dev. https:\/\/doi.org\/10.1002\/cpdd.1138 (2022).","DOI":"10.1002\/cpdd.1138"},{"key":"2168_CR36","doi-asserted-by":"publisher","unstructured":"Gege, C. et al. A helicase\u2013primase drug candidate with sufficient target tissue exposure affects latent neural herpes simplex virus infections. Sci. Transl. Med. https:\/\/doi.org\/10.1126\/scitranslmed.abf8668 (2021).","DOI":"10.1126\/scitranslmed.abf8668"},{"key":"2168_CR37","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/nm0402-386","volume":"8","author":"JJ Crute","year":"2002","unstructured":"Crute, J. J. et al. Herpes simplex virus helicase\u2013primase inhibitors are active in animal models of human disease. Nat. Med. 8, 386\u2013391 (2002).","journal-title":"Nat. Med."},{"key":"2168_CR38","doi-asserted-by":"publisher","first-page":"6979","DOI":"10.1128\/JVI.72.9.6979-6987.1998","volume":"72","author":"FC Spector","year":"1998","unstructured":"Spector, F. C., Liang, L., Giordano, H., Sivaraja, M. & Peterson, M. G. Inhibition of herpes simplex virus replication by a 2-amino thiazole via interactions with the helicase component of the UL5\u2013UL8\u2013UL52 complex. J. Virol. 72, 6979\u20136987 (1998).","journal-title":"J. Virol."},{"key":"2168_CR39","doi-asserted-by":"publisher","first-page":"32583","DOI":"10.1074\/jbc.M114.609453","volume":"289","author":"I Muylaert","year":"2014","unstructured":"Muylaert, I., Zhao, Z. & Elias, P. UL52 primase interactions in the herpes simplex virus 1 helicase\u2013primase are affected by antiviral compounds and mutations causing drug resistance. J. Biol. Chem. 289, 32583\u201332592 (2014).","journal-title":"J. Biol. Chem."},{"key":"2168_CR40","doi-asserted-by":"publisher","unstructured":"Patel, A., Toso, D., Litvak, A. & Nogales, E. Efficient graphene oxide coating improves cryo-EM sample preparation and data collection from tilted grids. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2021.03.08.434344 (2021).","DOI":"10.1101\/2021.03.08.434344"},{"key":"2168_CR41","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"2168_CR42","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1038\/s41592-020-00990-8","volume":"17","author":"A Punjani","year":"2020","unstructured":"Punjani, A., Zhang, H. & Fleet, D. J. Non-uniform refinement: adaptive regularization improves single-particle cryo-EM reconstruction. Nat. Methods 17, 1214\u20131221 (2020).","journal-title":"Nat. Methods"},{"key":"2168_CR43","doi-asserted-by":"publisher","unstructured":"Asarnow, D., Palovcak, E. & Cheng, Y. asarnow\/pyem: UCSF pyem v0.5. Zenodo https:\/\/doi.org\/10.5281\/zenodo.3576629 (2019).","DOI":"10.5281\/zenodo.3576629"},{"key":"2168_CR44","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.jsb.2012.09.006","volume":"180","author":"SH Scheres","year":"2012","unstructured":"Scheres, S. H. RELION: implementation of a Bayesian approach to cryo-EM structure determination. J. Struct. Biol. 180, 519\u2013530 (2012).","journal-title":"J. Struct. Biol."},{"key":"2168_CR45","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1038\/s41592-024-02304-8","volume":"21","author":"D Kimanius","year":"2024","unstructured":"Kimanius, D. et al. Data-driven regularization lowers the size barrier of cryo-EM structure determination. Nat. Methods 21, 1216\u20131221 (2024).","journal-title":"Nat. Methods"},{"key":"2168_CR46","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1038\/s42003-021-02399-1","volume":"4","author":"R Sanchez-Garcia","year":"2021","unstructured":"Sanchez-Garcia, R. et al. DeepEMhancer: a deep learning solution for cryo-EM volume post-processing. Commun. Biol. 4, 874 (2021).","journal-title":"Commun. Biol."},{"key":"2168_CR47","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583\u2013589 (2021).","journal-title":"Nature"},{"key":"2168_CR48","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF Chimera\u2013A visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput. Chem."},{"key":"2168_CR49","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr. D"},{"key":"2168_CR50","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1107\/S2059798318006551","volume":"74","author":"PV Afonine","year":"2018","unstructured":"Afonine, P. V. et al. Real-space refinement in PHENIX for cryo-EM and crystallography. Acta Crystallogr D 74, 531\u2013544 (2018).","journal-title":"Acta Crystallogr D"},{"key":"2168_CR51","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.str.2011.03.019","volume":"19","author":"MV Shapovalov","year":"2011","unstructured":"Shapovalov, M. V. & Dunbrack, R. L. Jr. A smoothed backbone-dependent rotamer library for proteins derived from adaptive kernel density estimates and regressions. Structure 19, 844\u2013858 (2011).","journal-title":"Structure"},{"key":"2168_CR52","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/978-1-60761-652-8_30","volume":"634","author":"BK Tischer","year":"2010","unstructured":"Tischer, B. K., Smith, G. A. & Osterrieder, N. En passant mutagenesis: a two step markerless red recombination system. Methods Mol. Biol. 634, 421\u2013430 (2010).","journal-title":"Methods Mol. Biol."},{"key":"2168_CR53","doi-asserted-by":"publisher","unstructured":"Kropp, K. A. et al. Herpes simplex virus 2 counteracts neurite outgrowth repulsion during infection in a nerve growth factor-dependent manner. J. Virol. https:\/\/doi.org\/10.1128\/JVI.01370-20 (2020).","DOI":"10.1128\/JVI.01370-20"},{"key":"2168_CR54","first-page":"146","volume":"78","author":"G Harauz","year":"1986","unstructured":"Harauz, G. & van Heel, M. Exact filters for general geometry three dimensional reconstruction. Optik 78, 146\u2013156 (1986).","journal-title":"Optik"},{"key":"2168_CR55","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1093\/nar\/gkx1217","volume":"46","author":"KY Lu","year":"2018","unstructured":"Lu, K. Y. et al. Insights into the structural and mechanistic basis of multifunctional S. cerevisiae Pif1p helicase. Nucleic Acids Res. 46, 1486\u20131500 (2018).","journal-title":"Nucleic Acids Res."},{"key":"2168_CR56","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1016\/j.cell.2006.10.049","volume":"127","author":"JY Lee","year":"2006","unstructured":"Lee, J. Y. & Yang, W. UvrD helicase unwinds DNA one base pair at a time by a two-part power stroke. Cell 127, 1349\u20131360 (2006).","journal-title":"Cell"},{"key":"2168_CR57","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.70080","volume":"96","author":"GB Effendi","year":"2024","unstructured":"Effendi, G. B. et al. Single amino acid substitution within the helicase of varicella zoster virus makes it resistant to amenamevir. J. Med. Virol. 96, e70080 (2024).","journal-title":"J. Med. Virol."},{"key":"2168_CR58","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.bcp.2012.05.020","volume":"84","author":"K Chono","year":"2012","unstructured":"Chono, K., Katsumata, K., Kontani, T., Shiraki, K. & Suzuki, H. Characterization of virus strains resistant to the herpes virus helicase\u2013primase inhibitor ASP2151 (amenamevir). Biochem. Pharmacol. 84, 459\u2013467 (2012).","journal-title":"Biochem. Pharmacol."},{"key":"2168_CR59","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1177\/095632020701800207","volume":"18","author":"S Biswas","year":"2007","unstructured":"Biswas, S., Swift, M. & Field, H. J. High frequency of spontaneous helicase\u2013primase inhibitor (BAY 57\u20131293) drug-resistant variants in certain laboratory isolates of HSV-1. Antivir. Chem. Chemother. 18, 111\u2013112 (2007).","journal-title":"Antivir. Chem. Chemother."}],"container-title":["Nature Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41564-025-02168-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41564-025-02168-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41564-025-02168-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T18:02:09Z","timestamp":1764612129000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41564-025-02168-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,4]]},"references-count":59,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2168"],"URL":"https:\/\/doi.org\/10.1038\/s41564-025-02168-4","relation":{},"ISSN":["2058-5276"],"issn-type":[{"value":"2058-5276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,4]]},"assertion":[{"value":"27 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors are current employees of Gilead Sciences, Inc. and received salary and stock ownership as compensation for their employment.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}